In a study of human bronchial epithelial cells from asthma patients, an IL-13-inducible gene signature (POSTN, CLCA1, and SERPINB2) was identified that served as a surrogate marker of type 2 airway inflammation. This evidence concerns the gene POSTN and asthma.